Neoarsphenamine (NARS), an organic trivalent arsenical compound, is a sulfhydryl-binding agent whose pharmalogical action in humans is well documented. Because it is a sulfhydryl-binding agent, the possibility that it would sensitize anoxic cells to ionizing radiation was investigated with the idea that such a sensitization could overcome the relative protection that severely hypoxic cells enjoy in certain parts of most human cancers. Micrococcus sodonensis and Escherichia coli K-12 AB1157 were both tested. Though both bacteria were sensitized, the latter is especially interesting because no sensitization occurred when NARS was used in an oxygenated medium. A sensitization factor [defined as the ratio of the slopes, where the slope of the curve refers to the relationship of the surviving fraction (ordinate) to the dose in kilorads (abscessa)] of approximately 2.2 was obtained with AB1157. The effect was reversed by an excess of cysteine added immediately before x-irradiation but was not lost by pre-x-ray washing of cells. Sensitization did not occur unless NARS was present before irradiation.
Skip Nav Destination
Research Article| September 01 1969
Sensitization of Bacteria to X-Ray by Neoarsphenamine
Radiat Res (1969) 39 (3): 571–579.
- Views Icon Views
- Share Icon Share
- Search Site
Morton M. Kligerman, Lee Schulhof; Sensitization of Bacteria to X-Ray by Neoarsphenamine. Radiat Res 1 September 1969; 39 (3): 571–579. doi: https://doi.org/10.2307/3572937
Download citation file:
Citing articles via
Commonalities Between COVID-19 and Radiation Injury
Carmen I. Rios, David R. Cassatt, Brynn A. Hollingsworth, Merriline M. Satyamitra, Yeabsera S. Tadesse, Lanyn P. Taliaferro, Thomas A. Winters, Andrea L. DiCarlo
Studies of the Mortality of Atomic Bomb Survivors, Report 14, 1950–2003: An Overview of Cancer and Noncancer Diseases
Kotaro Ozasa, Yukiko Shimizu, Akihiko Suyama, Fumiyoshi Kasagi, Midori Soda, Eric J. Grant, Ritsu Sakata, Hiromi Sugiyama, Kazunori Kodama
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks?
Pataje G. Prasanna, Gayle E. Woloschak, Andrea L. DiCarlo, Jeffrey C. Buchsbaum, Dörthe Schaue, Arnab Chakravarti, Francis A. Cucinotta, Silvia C. Formenti, Chandan Guha, Dale J. Hu, Mohammad K. Khan, David G. Kirsch, Sunil Krishnan, Wolfgang W. Leitner, Brian Marples, William McBride, Minesh P. Mehta, Shahin Rafii, Elad Sharon, Julie M. Sullivan, Ralph R. Weichselbaum, Mansoor M. Ahmed, Bhadrasain Vikram, C. Norman Coleman, Kathryn D. Held
Monte Carlo Simulation of SARS-CoV-2 Radiation-Induced Inactivation for Vaccine Development
Ziad Francis, Sebastien Incerti, Sara A. Zein, Nathanael Lampe, Carlos A. Guzman, Marco Durante
Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light
Manuela Buonanno, Brian Ponnaiya, David Welch, Milda Stanislauskas, Gerhard Randers-Pehrson, Lubomir Smilenov, Franklin D. Lowy, David M. Owens, David J. Brenner